Search

everythinglearnresearchcommunity

for

Search:↓

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

More research needed to confirm finasteride as standard treatment for FFA.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

The new drug delivery system effectively targets lung cancer cells.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Some drugs for inflammation may cause psoriasis-like hair loss.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Early combination therapy can effectively regrow hair in frontal fibrosing alopecia.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.